167 related articles for article (PubMed ID: 225521)
21. Cell surface glycoprotein patterns of two EBV-negative lines and their EBV converted sublines.
Koide N; Wells A; Klein G; Ernberg I
Intervirology; 1981; 16(3):142-8. PubMed ID: 6277822
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
Zimber-Strobl U; Suentzenich KO; Laux G; Eick D; Cordier M; Calender A; Billaud M; Lenoir GM; Bornkamm GW
J Virol; 1991 Jan; 65(1):415-23. PubMed ID: 1845900
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
Finke J; Rowe M; Kallin B; Ernberg I; Rosén A; Dillner J; Klein G
J Virol; 1987 Dec; 61(12):3870-8. PubMed ID: 2824821
[TBL] [Abstract][Full Text] [Related]
24. Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines.
Klein G; Zeuthen J; Terasaki P; Billing R; Honig R; Jondal M; Westman A; Clements G
Int J Cancer; 1976 Nov; 18(5):639-52. PubMed ID: 62724
[TBL] [Abstract][Full Text] [Related]
25. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule.
Abe M; Tasaki K; Tominaga K; Fukuhara S; Imai S; Osato T; Wakasa H
Cancer; 1992 Feb; 69(3):763-71. PubMed ID: 1309680
[TBL] [Abstract][Full Text] [Related]
26. Initiation points for cellular deoxyribonucleic acid replication in human lymphoid cells converted by Epstein-Barr virus.
Oppenheim A; Shlomai Z; Ben-Bassat H
Mol Cell Biol; 1981 Aug; 1(8):753-62. PubMed ID: 9279388
[TBL] [Abstract][Full Text] [Related]
27. Conversion of the lymphoma line "BJAB" by Epstein-Barr virus into phenotypically altered sublines is accompanied by increased c-myc mRNA levels.
Wennborg A; Aman P; Saranath D; Pear W; Sümegi J; Klein G
Int J Cancer; 1987 Aug; 40(2):202-6. PubMed ID: 3038758
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus.
Arcenas R; Widen RH
BMC Microbiol; 2002 Jul; 2():20. PubMed ID: 12137568
[TBL] [Abstract][Full Text] [Related]
29. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.
Knutson JC
J Virol; 1990 Jun; 64(6):2530-6. PubMed ID: 2159528
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneity of Epstein-Barr virus. IV. Induction of a specific antigen by EBV from two transformed marmoset cell lines in Ramos cells.
Fresen KO; Cho MS; zur Hausen H
Int J Cancer; 1978 Aug; 22(2):160-5. PubMed ID: 81181
[TBL] [Abstract][Full Text] [Related]
31. Integrated viral DNA sequences in Epstein-Barr virus-converted human lymphoma lines.
Andersson-Anvret M; Lindahl T
J Virol; 1978 Mar; 25(3):710-8. PubMed ID: 205668
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of acyclovir [9-(2-hydroxyethoxymethyl)guanine] in Epstein-Barr virus-infected lymphoblastoid cell lines.
Colby BM; Furman PA; Shaw JE; Elion GB; Pagano JS
J Virol; 1981 May; 38(2):606-11. PubMed ID: 6264131
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis.
Borkosky SS; Whitley C; Kopp-Schneider A; zur Hausen H; de Villiers EM
PLoS One; 2012; 7(2):e32160. PubMed ID: 22384166
[TBL] [Abstract][Full Text] [Related]
34. Search for inhibitors against herpes simplex virus type-I in cell extracts derived from human lymphoblastoid cell lines.
Lin KH
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1977 Jun; 10(1-2):14-20. PubMed ID: 196817
[TBL] [Abstract][Full Text] [Related]
35. High Epstein-Barr virus (EBV) susceptibility of both lymphoblastoid and lymphoma cell lines derived from a Japanese patient with EBV genome-positive Burkitt's lymphoma.
Okano M; Aya T; Mizuno F; Takada K; Osato T
Tohoku J Exp Med; 1993 Jun; 170(2):71-9. PubMed ID: 8266328
[TBL] [Abstract][Full Text] [Related]
36. Retrovirus-like particles in EBV-negative Burkitt's lymphoma cell line but not in EBV-DNA-positive lines from patients with ataxia telangiectasia and Down's syndrome.
Kotler M; Balabanova H; Friedmann A; Becker Y
Br J Cancer; 1979 Apr; 39(4):414-21. PubMed ID: 220999
[TBL] [Abstract][Full Text] [Related]
37. State of Epstein-Barr virus DNA in an American Burkitt's lymphoma line.
Koliais S; Bjursell G; Adams A; Lindahl T; Klein G
J Natl Cancer Inst; 1978 May; 60(5):991-4. PubMed ID: 205666
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.
Marchini A; Longnecker R; Kieff E
J Virol; 1992 Aug; 66(8):4972-81. PubMed ID: 1321281
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus infection is associated with increased apoptosis in untreated and phorbol ester-treated human Burkitt's lymphoma (AW-Ramos) cells.
Ishii HH; Gobé GC
Biochem Biophys Res Commun; 1993 May; 192(3):1415-23. PubMed ID: 8389551
[TBL] [Abstract][Full Text] [Related]
40. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
Menezes J; Leibold W; Klein G; Clements G
Biomedicine; 1975 Jul; 22(4):276-84. PubMed ID: 179629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
